|Last Price||Today's Change||52-Week Range||Trading Volume|
|23.35||0.64 (+2.82%)||6.86 - 24.12||2.4 million (Below Avg)|
Market data as of 3:59PM 03/11/14. Quotes are delayed by at least 15 min.
Marketing Authorization Applications, Quarterly Dividends, Publication of Clinical Trial Data, Acquisitions, and Financial Results - Analyst Notes on Regeneron, Amgen, Sangamo, Alnylam, and Agios
03/11/2014 9:08 AM ET
Sangamo Presents Clinical Data At CROI 2014 Demonstrating Enhancement Of SB-728-T Engraftment - Continued Control Of HIV Viral Load For 31 Weeks Without ART In SB-728-T Treated Subject
03/06/2014 12:16 PM ET